Header Logo

Connection

MASATAKA SUZUKI to Leukemia, Myeloid, Acute

Back to Details
This is a "connection" page, showing publications MASATAKA SUZUKI has written about Leukemia, Myeloid, Acute.
MASATAKA SUZUKI
Connection Strength
0.059
Leukemia, Myeloid, Acute
  1. LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy. Cancer Res. 2023 12 15; 83(24):4047-4062.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.